Wake Forest University Health Sciences
The study team will assess the efficacy of platelet-rich plasma therapy, a special blood product which is from the participant's own body, in the treatment of androgenic alopecia (also known as male pattern hair loss) in females.
Androgenic alopecia, or male-pattern hair loss affects both men and women. This hair loss pattern is typically characterized by thinning at the crown of scalp and/or M-shaped hair line in males or diffuse thinning throughout in females. Platelet-rich plasma (PRP) therapy has recently been studied as a hair rejuvenation therapy in patients with non-inflammatory alopecia. Though the mechanism of action is not well understood, PRP is thought to promote angiogenesis and enhance blood flow around hair follicles via platelet-derived growth factor (PDGF), transforming growth factor (TGF), and vascula…
Inclusion Criteria: * Female ≥18 years of age at baseline visit. * Documentation of androgenic alopecia diagnosis as evidenced by one or more clinical features * Not currently on any treatment for alopecia, or has undergone 2-week washout period if recently on medication(s) for alopecia * Written informed consent obtained from subject and ability for subject to comply with the requirements of the study Exclusion Criteria: * Pregnant or breastfeeding * Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of t…
Group A will receive PRP on left side of scalp and placebo (saline solution) on right side of scalp.
Group B will receive PRP on right side of scalp and placebo (saline solution) on left side of scalp.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.